Literature DB >> 3284066

The influence of cyclosporine A treatment on immune responsiveness in vitro and in vivo in kidney transplant recipients.

A A van der Heyden1, M H van Oers, P Cornelissen, S L Yong, J M Wilmink, P T Schellekens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3284066      PMCID： PMC3000132     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

Review 1.  Metabolism of cyclosporine.

Authors:  G Maurer
Journal:  Transplant Proc       Date:  1985-08       Impact factor: 1.066

2.  Excretion of cyclosporine and its metabolites in human bile.

Authors:  G J Burckart; T E Starzl; R Venkataramanan; H Hashim; L Wong; P Wang; L Makowka; A Zeevi; R J Ptachcinski; J E Knapp
Journal:  Transplant Proc       Date:  1986-12       Impact factor: 1.066

3.  Specificity of alloactivated human T lymphocyte clones in secondary proliferation, cell-mediated lympholysis and interleukin-2 release.

Authors:  A Zeevi; R J Duquesnoy
Journal:  J Immunogenet       Date:  1985-02

4.  In vitro immunosuppressive properties of cyclosporine metabolites.

Authors:  B M Freed; T G Rosano; N Lempert
Journal:  Transplantation       Date:  1987-01       Impact factor: 4.939
  4 in total
  1 in total

1.  The kinetics of cyclosporine and its metabolites in bone marrow transplant patients.

Authors:  T L Schwinghammer; D Przepiorka; R Venkataramanan; C P Wang; G J Burckart; C S Rosenfeld; R K Shadduck
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.